<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02445235</url>
  </required_header>
  <id_info>
    <org_study_id>IFG2015-SOPWS</org_study_id>
    <nct_id>NCT02445235</nct_id>
  </id_info>
  <brief_title>Study to Evaluate Outcomes of Patients Receiving Treatment for Wound Care, Pain Management or Surface Skin Scar Therapy</brief_title>
  <acronym>SOPWS</acronym>
  <official_title>Study to Evaluate Outcomes of Patients Receiving Treatment for Wound Care, Pain Management or Surface Skin Scar Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bracane Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IFG Medical</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Bracane Company</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational study is designed to evaluate the reported outcomes for patients receiving
      topical therapy for the treatment of pain, fungal infections or skin scars. The patients will
      complete the Patient Reported Outcome (PRO) survey monthly and provide valuable data on the
      patients perception of their health status and well being while receiving therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This observational study is designed to evaluate the reported outcomes for patients receiving
      topical therapy for the treatment of pain, fungal infections or skin scars. The patients will
      complete the Patient Reported Outcome (PRO) survey monthly and provide valuable data on the
      patients perception of their health status and well being while receiving therapy.

      Patients are enrolled for 18 months. The investigator will complete a global patient
      assessment monthly of the patient's condition.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sponsor discretion determined no clinical benefit
  </why_stopped>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Baseline PRO and Health Status Perception</measure>
    <time_frame>Up to eighteen (18) months</time_frame>
  </primary_outcome>
  <enrollment type="Actual">88</enrollment>
  <condition>Chronic Pain</condition>
  <condition>Fungal Infection</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient Reported Outcome Survey Tool</intervention_name>
    <description>Patient Reported Outcome Survey Tool</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Must be receiving therapy for pain, wound care or scar therapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. An 18 to 85 years old (inclusive) female or male patient

          2. Prescribed compound for the treatment of pain, wound healing or surface skin scar by
             their Principal Investigator

          3. Any systemic disease (cardiac, renal, or hepatic) must be well controlled.

          4. Has no skin lesions at the site of application of study medication except for wound
             under treatment

          5. Able to provide informed consent

        Exclusion Criteria:

          1. Pregnant or lactating females or women at the child bearing potential not using
             effective contraception.

          2. Use of other topical or transdermal medication. Patients may be withdrawn for a period
             of 2 weeks from all topical or transdermal medications prior to study initiation.

          3. Hypersensitivity to local anesthetic or other ingredients of the compounded creams to
             be used in a study.

          4. Prior reconstruction skin surgery or skin grafts in the area of cream application
             preventing absorption of cream except for the treatment of surface skin scar

          5. Chronic pain conditions not expected to respond to topical pain medication such as
             deep abdominal pain, or from conditions such as cancer, or gouty arthritis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pamela Nelson, RN, MS</last_name>
    <role>Study Director</role>
    <affiliation>Bracane Company</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matt Fruge, BS</last_name>
    <role>Study Chair</role>
    <affiliation>IFG Medical</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BG Research</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>KY</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sevierville Foot and Ankle Clinic</name>
      <address>
        <city>Sevierville</city>
        <state>Tennessee</state>
        <zip>37862</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Associates of Internal Medicine</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2015</study_first_submitted>
  <study_first_submitted_qc>May 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2015</study_first_posted>
  <last_update_submitted>January 18, 2016</last_update_submitted>
  <last_update_submitted_qc>January 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pain</keyword>
  <keyword>wound care</keyword>
  <keyword>fungal infections</keyword>
  <keyword>scars</keyword>
  <keyword>chronic pain</keyword>
  <keyword>outcomes</keyword>
  <keyword>PRO</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Mycoses</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

